Drug
haloperidole
haloperidole is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
50%(1 trials)
Phase Distribution
Ph phase_4
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution3 total trials
Phase 4Post-market surveillance
3(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Terminated(1)
Detailed Status
Completed2
Withdrawn1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 43 (100.0%)
Trials by Status
completed267%
withdrawn133%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_4
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
NCT01157351
withdrawnphase_4
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
NCT01193166
completedphase_4
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
NCT00433121
Clinical Trials (3)
Showing 3 of 3 trials
NCT01157351Phase 4
15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated
NCT01193166Phase 4
Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital
NCT00433121Phase 4
Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3